drugset / Trial / NCT05535075

Model-informed Precision Dosing of Vancomycin in Adults

NCT05535075

Phase 4 Completed 155 enrolled University Hospital, Ghent
RandomizedParallel-groupDouble-blindTreatment

Summary

The overall objective of this project is to investigate the utility of model-informed precision dosing (MIPD) of vancomycin in non-critically ill adults. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.

Timeline

Start
2021-11-12
Primary completion
2023-11-17
Completion
2023-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified

Indications

No indication recorded.